Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,506Revenue $M2,360Net Margin (%)15.0Altman Z-Score6.5
Enterprise Value $M9,715EPS $2.1Operating Margin %17.7Piotroski F-Score5
P/E(ttm)27.6Beneish M-Score-2.4Pre-tax Margin (%)19.0Higher ROA y-yN
Price/Book5.510-y EBITDA Growth Rate %31.9Quick Ratio1.5Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %36.7Current Ratio1.9Lower Leverage y-yY
Price/Free Cash Flow63.0y-y EBITDA Growth Rate %6.9ROA % (ttm)12.3Higher Current Ratio y-yN
Dividend Yield %0.5PEG0.7ROE % (ttm)22.1Less Shares Outstanding y-yN
Payout Ratio %14.0Shares Outstanding M170ROIC % (ttm)19.0Gross Margin Increase y-yY

Gurus Latest Trades with RDY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RDYKen Fisher 2015-03-31 Add0.12%$47.73 - $57.1
($53.03)
$ 55.595%Add 25.58%5,216,225
RDYKen Fisher 2014-06-30 Add0.13%$38.67 - $46.08
($42.03)
$ 55.5932%Add 62.43%3,773,114
RDYKen Fisher 2014-03-31 Add0.08%$39.5 - $47.4
($43.29)
$ 55.5928%Add 56.30%2,322,863
RDYKen Fisher 2013-06-30 Add0.04%$32.98 - $38.7
($36.5)
$ 55.5952%Add 48.42%1,283,605
RDYKen Fisher 2013-03-31 Add0.02%$32.03 - $36.57
($34.21)
$ 55.5962%Add 31.46%864,830
RDYKen Fisher 2012-09-30 Buy 0.05%$28.94 - $32.58
($30.12)
$ 55.5985%New holding604,555
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RDY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about RDY:

    News about RDY:

    Articles On GuruFocus.com
    Emerging Market Stocks To Watch Out For Feb 17 2015 
    Should You Buy Actavis? Mar 18 2014 
    Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
    5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
    Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 
    Dr. Reddy’s Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 m Jan 20 2009 

    More From Other Websites
    Dr. Reddy’s Unveils New Corporate Brand Identity Jul 01 2015
    Dr. Reddy’s Unveils New Corporate Brand Identity Jul 01 2015
    New Strong Sell Stocks for June 29th - Tale of the Tape Jun 29 2015
    Indian drug maker recalls two medicines from US Jun 29 2015
    Dr Reddy's launches hair growth supplement Jun 19 2015
    Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F Jun 18 2015
    Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F Jun 18 2015
    What Lies Ahead for the Modi Government? Jun 09 2015
    Dr Reddy’s Laboratories Limited and AstraZeneca Pharma India Limited entered into a distribution... Jun 09 2015
    Dr. Reddy’s launches Somazina® for stroke patients in India Jun 09 2015
    Dr. Reddy’s Q4 FY15 Financial Results Q4 FY15 Revenues at Rs.38.7 billion Q4 FY15 EBITDA at Rs.8.1... Jun 09 2015
    Satish Reddy Appointed as National Safety Council Chairman Jun 09 2015
    India Pharma: A Pill In Healthy Portfolios? Jun 04 2015
    How to Profit from the Generic Drug Trend Jun 03 2015
    Foreign Direct Investment in India Up 61% since Last Year May 31 2015
    New Strong Sell Stocks for May 29th - Tale of the Tape May 29 2015
    Pfizer Gets OK On Drug For Rare Lung Disorder May 29 2015
    Dr. Reddy's (RDY) Earnings and Revenues Rise in Q4 - Analyst Blog May 13 2015
    Dr. Reddy’s Q4 & FY15 Financial Results May 12 2015
    Dr.Reddy's Q4 net up 8 percent May 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK